Billy Roberts
Impact in
- Organic Chemistry top 5%
- Quinazolinone synthesis and applications
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Metal complexes synthesis and properties
Papers in
- Oncology 7
- HER2/EGFR in Cancer Research 3
-
- Quinazolinone synthesis and applications 2
- Ferrocene Chemistry and Applications 2
- Co-authors
- Wilbur R. Leopold (6 shared papers)William L. Elliott (6 shared papers)James M. Nelson (4 shared papers)H. D. Hollis Showalter (4 shared papers)David W. Fry (5 shared papers)Patrick W. Vincent (3 shared papers)William A. Denny (3 shared papers)R. Thomas Winters (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)Investigational New Drugs (2 papers)Solar Energy (1 paper)Data in Brief (1 paper)
- Partner nations
- United StatesNew Zealand
In The Last Decade
Billy Roberts
17 papers receiving 717 citations
Peers
Comparison fields: 5 of 88
- Organic Chemistry 349
- Oncology 292
- Toxicology 30
- Molecular Biology 291
- Energy Engineering and Power Technology 12
Countries citing papers authored by Billy Roberts
This map shows the geographic impact of Billy Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Roberts more than expected).
Fields of papers citing papers by Billy Roberts
This network shows the impact of papers produced by Billy Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Roberts. The network helps show where Billy Roberts may publish in the future.
Co-authors
The 25 scholars most cited alongside Billy Roberts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 169 | |
| 2 | 1998 | 103 | |
| 3 | 2006 | 75 | |
| 4 | Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues. | 1984 | 74 |
| 5 | Toxicity and anticancer activity of a new triazine antifolate (NSC 127755). | 1982 | 63 |
| 6 | 1994 | 59 | |
| 7 | 1995 | 56 | |
| 8 | 1985 | 39 | |
| 9 | 2000 | 38 | |
| 10 | 2018 | 29 | |
| 11 | 2024 | 19 | |
| 12 | 1981 | 13 | |
| 13 | 1991 | 9 | |
| 14 | 2022 | 5 | |
| 15 | 2018 | 5 | |
| 16 | 2018 | 4 | |
| 17 | 2020 | 1 | |
| 18 | 2024 | 0 |
About Billy Roberts
Billy Roberts is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Artificial Intelligence and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 761 indexed citations. Recurring topics across this work include Solar Radiation and Photovoltaics (4 papers), Cancer therapeutics and mechanisms (4 papers), HER2/EGFR in Cancer Research (3 papers), Quinazolinone synthesis and applications (2 papers), Solar Thermal and Photovoltaic Systems (2 papers), Climate variability and models (2 papers), Ferrocene Chemistry and Applications (2 papers) and Effects of Radiation Exposure (2 papers). The work is most often cited by research in Organic Chemistry (349 citations), Oncology (292 citations), Toxicology (30 citations), Molecular Biology (291 citations) and Energy Engineering and Power Technology (12 citations). Billy Roberts has collaborated with scholars based in United States and New Zealand. Frequent co-authors include Wilbur R. Leopold, William L. Elliott, James M. Nelson, H. D. Hollis Showalter, David W. Fry, Patrick W. Vincent, William A. Denny, R. Thomas Winters, Robert Jackson and Gordon W. Rewcastle. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, Solar Energy and Data in Brief.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.